Antibody Testing Market

Antibody Testing Market Outlook (2024 to 2034)

The global antibody testing market size is pegged at US$ 9.17 billion in 2024, according to a new study published by Fact.MR. Global demand for antibody testing products is predicted to increase at 7.5% CAGR and reach a market value of US$ 18.89 billion by 2034-end.

Rising cases of chronic diseases, including cancer, infectious diseases, and autoimmune diseases are predicted to lead to an increased need for immunoassays to diagnose and monitor these health issues. The adoption of antibody tests is forecasted to assist in providing effective healthcare solutions.

More biotechnology and pharmaceutical companies are investing in R&D activities to develop more rapid, accurate, and sensitive testing techniques. Several innovations, including automated testing systems and point-of-care testing, are predicted to improve the quality of services offered to patients. Public health awareness campaigns are estimated to promote regular health screening programs and are predicted to stimulate demand for antibody testing equipment.

Antibody testing plays a crucial role in the monitoring and development of treatments, including personalized medicine and immunotherapy, thereby ensuring quality treatment for patients.

• Demand for antibody testing in China is projected to rise at 10% CAGR and reach a valuation of US$ 1.73 billion by the end of 2034.
• Sales of serological test equipment are forecasted to expand at 8.6% CAGR and reach US$ 7.82 billion by the end of 2034.
• Diagnostic laboratories are estimated to account for 39.8% share of the global market by the end of 2034.

Implementation of more supportive government regulations, guidelines, and policies related to diagnostics and disease control is projected to contribute to the expansion of the antibody testing market size. In recent years, the inclination toward personalized medicine by more patients is forecasted to contribute to the antibody testing market trends.

Results of diagnostic methods are predicted to directly impact the decisions taken by healthcare professionals. In addition, the growing prevalence of laboratory automation is predicted to help healthcare providers in offering more effective services.

Report Attributes	Details
Antibody Testing Market Size (2024E)	US$ 9.17 Billion
Forecasted Market Value (2034F)	US$ 18.89 Billion
Global Market Growth Rate (2024 to 2034)	7.5% CAGR
North America Market Share (2034F)	37.1%
Japan Market Value (2034F)	US$ 1.1 Billion
Canada Market Growth Rate (2024 to 2034)	7.4% CAGR
Serological Tests Segment Value (2034F)	US$ 7.82 Billion
Diagnostic Laboratories Segment Share (2034F)	39.8%
Key Companies Profiled	Thermos Fisher Scientific Abbott Laboratories Bio-Rad Laboratories, Inc. F. Hoffmann La Roche Beckton Agilent Technologies Dickinson and Company DiaSorin Trinity Biotech Abcam Zeus Scientific

Why is Demand for Antibody Testing Increasing Significantly across the World?

“Rising Cases of Chronic and Autoimmune Diseases Worldwide”

Increasing demand for antibody tests is attributed to the rising cases of chronic diseases, including, cancer, autoimmune disorders, and infectious diseases. Need for immunoassays, including antibody tests, is predicted to contribute significantly to the treatment of cancer. These test kits can detect some tumor-associated antigens or particular biomarkers present in blood samples, thus aiding in the early detection, monitoring, and staging of cancer progression. Examples include the adoption of the CA-125 test for the cancer of the ovary or the PSA (prostate-specific antigen) for prostate cancer, which are available immunoassays in cancer diagnosis.

Immunoassays are pivotal in the diagnosis of autoimmune disorders, in which the immune system of the body mistakenly attacks its tissues. Antibody tests contribute significantly to the identification of autoantibodies present in autoimmune conditions, including lupus, rheumatoid, celiac diseases, and multiple sclerosis. These tests help clinicians in getting confirmation about diagnosis, guiding appropriate treatment strategies, and understanding disease severity.

For infectious diseases, antibody tests are used extensively for their diagnosis and surveillance. They help in the detection of antibodies produced through the immune system against pathogens, including bacteria, parasites, and viruses.

“Government Support and Regulations to Ensure Efficacy and Reliability of Tests”

Regulatory bodies and government health agencies, including the European Medicines Agency (EMA), or the Food and Drug Administration (FDA) in the United States, establish stringent regulations for the approval, manufacturing, and distribution of most medical devices. Compliance with these regulations is pivotal to ensure the efficacy, reliability, and safety of these tests.

Certain quality assurance protocols are set by more governments to ensure that these antibody tests match specific performance criteria before their clinical use. Regular monitoring and inspections of laboratories and manufacturing sites are conducted to test quality standards, thus ensuring the reliability of these diagnostic tools.

Government healthcare policies influence reimbursement mechanisms for diagnostic tests and medical procedures. With the adoption of favorable reimbursement policies, healthcare providers are predicted to adopt antibody tests.

What are the Challenges Adversely Impacting Market Growth?

“Limitations of Present Diagnostics and Stringent Regulatory Impositions”

Most governments are establishing regulations on the medical device and pharmaceutical industries through some specialized regulatory bodies to safeguard citizens against low-performing products. These restrictions are predicted to delay the introduction of novel diagnostic products. It becomes challenging for small participants to adhere to set regulations.

Prolonged trial periods are predicted to adversely impact the outcomes of antibody testing. Limitations of current testing methods are predicted to adversely impact market expansion.

What Opportunities Await Start-ups in This Business Space?

“Rising Investments by Start-ups in Development of Innovative Testing Technologies”

The development of more efficient and novel antibody testing methods is predicted to generate revenue streams for new entrants. This is forecasted to involve the production of cost-effective, more sensitive, and faster assays, which can detect antibodies accurately. The use of advanced biotechnological methods, including nanotechnology, microfluidics, etc., benefits start-ups.

Country-wise Insights

As per the study published by Fact.MR, a market research and competitive intelligence provider, North America is predicted to hold 37.1% share of global market revenue by 2034. The dominance of the region is attributed to the presence of several new players, investments in clinical diagnostic businesses, and product launches.

What is Driving Demand for Antibody Testing in the United States?

“Presence of Supportive Reimbursement Policies”

Attribute	United States
Market Value (2024E)	US$ 2.83 Billion
Growth Rate (2024 to 2034)	8.4% CAGR
Projected Value (2034F)	US$ 6.36 Billion

The United States is projected to hold 90.8% share of the North American market by the end of 2034. Rising cases of autoimmune diseases are predicted to result in the growing demand for antibody tests in the United States. Several government initiatives are taken to increase public awareness about the benefits of health insurance programs, which is forecasted to contribute to the rising adoption of antibody testing and drive the antibody testing market growth.

Why are Antibody Testing Providers Focusing on China?

“Increasing R&D Spending to Develop Biospecific Antibody Tests”

Attribute	China
Market Value (2024E)	US$ 667.4 Million
Growth Rate (2024 to 2034)	10% CAGR
Projected Value (2034F)	US$ 1.73 Billion

China is predicted to hold 54% share of the East Asia market by 2034. R&D firms in China are focusing on the development of biospecific antibody tests. Market growth in China is attributed to the discovery of several innovative biospecific antibodies. In addition, players in China are focusing on product launches to offer more effective services and generate new leads, thus boosting their profit margins.

Category-wise Insights

According to Fact.MR’s report, worldwide demand for serological tests is predicted to increase significantly due to their ability to offer more accurate and rapid results.

Which Antibody Testing Product is Extensively Adopted?

“Preference for Serological Tests Due to Ease of Diagnosis and Rapid Results”

Attribute	Serological Test Kits
Segment Value (2024E)	US$ 3.41 Billion
Growth Rate (2024 to 2034)	8.6% CAGR
Projected Value (2034F)	US$ 7.82 Billion

Serological test kits are predicted to hold 41.4% of the antibody testing market share by 2034. Several benefits are associated with serology tests, including quick turnaround and potential for patient involvement. In addition, the increasing burden of diseases is predicted to widen the adoption of serological test kits for accurate and quick results.

Which Indication is Antibody Testing Products Widely Used For?

“Rising Burden of Infectious Diseases Due to Climate Change Driving Adoption of Antibody Testing”

Attribute	Infectious Diseases
Segment Value (2024E)	US$ 2.09 Billion
Growth Rate (2024 to 2034)	9.5% CAGR
Projected Value (2034F)	US$ 5.15 Billion

Infectious diseases are forecasted to hold 27.3% share of global market revenue by 2034. Antibodies in the human body serve as a defense mechanism and typically help in the prevention of diseases. Increased global prevalence of infectious diseases is attributed to climate change. The rising burden of the prevalence of infectious diseases is predicted to stimulate demand for antibody test kits from 2024 to 2034.

Which End User is Forecasted to Offer Profitable Opportunities for Antibody Testing Providers?

“Market Benefitting from Investments by Diagnostic Laboratories in Innovative Technologies”

Attribute	Diagnostic Laboratories
Segment Value (2024E)	US$ 3.29 Billion
Growth Rate (2024 to 2034)	8.6% CAGR
Projected Value (2034F)	US$ 7.51 Billion

Diagnostic laboratories are projected to hold 39.8% share of global market revenue by 2034. Increased investments in diagnostic and clinical research and the availability of reimbursement policies are contributing to the rising adoption of antibody tests across diagnostic laboratories. Diagnostic laboratories are also investing significantly in the adoption of more innovative technologies to offer quality healthcare services.

Market Players

Suppliers of antibody testing products are adopting cutting-edge technologies to develop new equipment to get more accurate results. Moreover, players are also investing in R&D activities for new developments, ensuring quality control of products, supply chain management systems, collaborations, etc.

For instance :

• Cancer Research UK and Abcam Plc. collaborated in July 2020 for the manufacturing and commercialization of novel custom antibodies.

Key players in the antibody testing market are Thermos Fisher Scientific, Abbott Laboratories, Bio-Rad Laboratories, Inc., F. Hoffmann La Roche, Beckton, Agilent Technologies, Dickinson and Company, DiaSorin, Trinity Biotech, Abcam, and Zeus Scientific.

Segmentation of Antibody Testing Market Research

• By Product :

  • Serological Test Kits
    • Serological Assay Test Kits
    • Serological Rapid Assay Kits
  • Immunoglobulin Kits
    • Immunoglobulin Assay Test Kits
    • Immunoglobulin Rapid Assay Kits
  • Lateral Flow Assay Kits
    • Lateral Flow Assay Test Kits
    • Lateral Flow Rapid Assay Kits
  • Chemicals & Reagents
  • Consumables

• By Indication :

  • Pregnancy
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Infectious Diseases
  • Oncology
  • Endocrine Diseases
  • Diabetes

• By End User :

  • Hospitals
  • Academic & Research Institutes
  • Diagnostic Laboratories
  • Biopharmaceutical Companies
  • Homecare Settings

• By Region :

  • North America
  • Europe
  • East Asia
  • Latin America
  • Middle East & Africa
  • South Asia & Oceania